These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33193280)

  • 1. Comparative Analysis of Virulence and Toxin Expression of Vancomycin-Intermediate and Vancomycin-Sensitive
    Jin Y; Yu X; Zhang S; Kong X; Chen W; Luo Q; Zheng B; Xiao Y
    Front Microbiol; 2020; 11():596942. PubMed ID: 33193280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin-intermediate Staphylococcus aureus isolates are attenuated for virulence when compared with susceptible progenitors.
    Cameron DR; Lin YH; Trouillet-Assant S; Tafani V; Kostoulias X; Mouhtouris E; Skinner N; Visvanathan K; Baines SL; Howden B; Monk IR; Laurent F; Stinear TP; Howden BP; Peleg AY
    Clin Microbiol Infect; 2017 Oct; 23(10):767-773. PubMed ID: 28396035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia.
    Howden BP; Smith DJ; Mansell A; Johnson PD; Ward PB; Stinear TP; Davies JK
    BMC Microbiol; 2008 Feb; 8():39. PubMed ID: 18304359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic Characteristics of Vancomycin-Non-Susceptible Staphylococcus aureus.
    Sirichoat A; Wongthong S; Kanyota R; Tavichakorntrakool R; Chanawong A; Welbat JU; Lulitanond A
    Jundishapur J Microbiol; 2016 Jan; 9(1):e26069. PubMed ID: 27099678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of amino acid changes in the yvqF, vraSR, graSR, and tcaRAB genes from vancomycin intermediate resistant Staphylococcus aureus.
    Yoo JI; Kim JW; Kang GS; Kim HS; Yoo JS; Lee YS
    J Microbiol; 2013 Apr; 51(2):160-5. PubMed ID: 23625215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of extracellular polysaccharide and biofilm under different oxygen conditions by clinical isolates of Staphylococcus aureus non-susceptible to glycopeptides.
    Szymanek-Majchrzak K; Wodzyńska S; Młynarczyk A; Młynarczyk G
    Przegl Epidemiol; 2018; 72(4):487-498. PubMed ID: 30810004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Howden BP; Johnson PD; Ward PB; Stinear TP; Davies JK
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3039-47. PubMed ID: 16940100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VraR Binding to the Promoter Region of
    Dai Y; Chang W; Zhao C; Peng J; Xu L; Lu H; Zhou S; Ma X
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA.
    Howden BP; Peleg AY; Stinear TP
    Infect Genet Evol; 2014 Jan; 21():575-82. PubMed ID: 23567819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated Exposure of Vancomycin to Vancomycin-Susceptible Staphylococcus aureus (VSSA) Parent Emerged VISA and VRSA Strains with Enhanced Virulence Potentials.
    Nguyen A; Roy JJS; Kim JH; Yun KH; Lee W; Kim KK; Kim T; Chaurasia AK
    J Microbiol; 2024 May; ():. PubMed ID: 38814539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of RNAIII in vancomycin-intermediate Staphylococcus aureus strains regardless of the presence of agr mutation.
    Park C; Shin NY; Byun JH; Shin HH; Kwon EY; Choi SM; Kim SH; Kwon JC; Park SH; Choi JH; Yoo JH; Yoo JI; Chung GT; Lee DG
    J Med Microbiol; 2012 Mar; 61(Pt 3):345-352. PubMed ID: 22016559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic characteristics and comparative proteomics of Staphylococcus aureus strains with different vancomycin-resistance levels.
    Sirichoat A; Lulitanond A; Kanlaya R; Tavichakorntrakool R; Chanawong A; Wongthong S; Thongboonkerd V
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):340-344. PubMed ID: 27717648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate
    Hu Q; Peng H; Rao X
    Front Microbiol; 2016; 7():1601. PubMed ID: 27790199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and Molecular Characterisation of Staphylococcus Aureus with Reduced Vancomycin Susceptibility Derivated in Vitro.
    Xu J; Pang L; Ma XX; Hu J; Tian Y; Yang YL; Sun DD
    Open Med (Wars); 2018; 13():475-486. PubMed ID: 30426085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Detection of Vancomycin-Intermediate Staphylococcus aureus by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.
    Mather CA; Werth BJ; Sivagnanam S; SenGupta DJ; Butler-Wu SM
    J Clin Microbiol; 2016 Apr; 54(4):883-90. PubMed ID: 26763961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate
    Lin LC; Chang SC; Ge MC; Liu TP; Lu JJ
    Infect Drug Resist; 2018; 11():113-123. PubMed ID: 29403293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced susceptibility to vancomycin in isogenic Staphylococcus aureus strains of sequence type 59: tracking evolution and identifying mutations by whole-genome sequencing.
    Chen CJ; Lin MH; Shu JC; Lu JJ
    J Antimicrob Chemother; 2014 Feb; 69(2):349-54. PubMed ID: 24092658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of vancomycin-intermediate Staphylococcus aureus among clinical isolates in Iran: A systematic review and meta-analysis.
    Baseri N; Najar-Peerayeh S; Bagheri Amiri F
    J Glob Antimicrob Resist; 2018 Dec; 15():178-187. PubMed ID: 29981455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings.
    Spagnolo AM; Orlando P; Panatto D; Amicizia D; Perdelli F; Cristina ML
    J Prev Med Hyg; 2014 Dec; 55(4):137-44. PubMed ID: 26137787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuated total reflection: Fourier transform infrared spectroscopy for detection of heterogeneous vancomycin-intermediate Staphylococcus aureus.
    Wongthong S; Tippayawat P; Wongwattanakul M; Poung-Ngern P; Wonglakorn L; Chanawong A; Heraud P; Lulitanond A
    World J Microbiol Biotechnol; 2020 Jan; 36(2):22. PubMed ID: 31955251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.